In line with the TCGA outcomes, up-regulated HNRNPA2B1 is concluded to promote breast cancer tumorigenic potential by activating extracellular-signal-regulated kinase 1/2 (ERK1/2), and signal transducer and activator of transcription 3 (STAT3). The gene discussed is MAPK3; the disease is breast carcinoma.